Department of Cardiology, Second Hospital of Hebei Medical University, Hebei, China.
Clin Cardiol. 2024 Feb;47(2):e24185. doi: 10.1002/clc.24185. Epub 2023 Nov 17.
Recent studies suggested that the left bundle branch area pacing (LBBAP) has a better efficacy to reduce QRS duration and produce a lower pacing threshold than the conventional right ventricular outflow tract septal pacing (RVOP), which resulted in a better cardiac function and ventricular synchronization. However, whether the LBBAP has a better efficacy in improving left atrial structure, function in pace-dependent patients compared with RVOP has not been well studied.
The purpose of this study was to compare the atrial outcomes of pace-dependent patients who received LBBAP or RVOP procedures.
A total of 72 patients (including II° AVB, high AVB, and III° AVB, excluding atrial fibrillation patients with atrioventricular block) consecutively enrolled in this single-center prospective clinical study and randomly assigned to the RVOP group and the LBBP group with 36 patients. All patients were pace-dependent. The changes in echocardiogram, speckle-tracking echocardiography, brain natriuretic peptide (BNP), and 6-min walking distance were documented and compared between two groups at baseline, 7 days, 1, 3, and 6 months after the implantation. There were no significant differences in baseline characteristics between the two groups. The results of the study were as following: (1) left atrial structure index: Our study indicated that there are no significant differences in left atrial anteroposterior dimension (LAAPD), left atrial superoinferior dimension, and left atrial mediolateral dimension between two groups. While the LAAPD in the LBBAP group was significantly reduced at 6 months after implantation ([38.22 ± 2.17] mm vs. [34.13 ± 1.59] mm, p < .05). (2) Left atrial strain index: We observed that the S% was significantly improved in both groups at 3 and 6 months after implantation but more prominent in the LBBAP group at 6 months (36.94 ± 11.67 vs. 25.87 ± 8.93, p = .01). SRs, SRe were improved in the RVOP group at 6 months after implantation but was further significantly increased in the LBBAP group. Similarly, the SRa in the LBBAP group was significantly better than the RVOP group after 6 months (-2.11 ± 0.75 vs. -2.51 ± 0.70, p = .04). (3) Left atrial ejection index: LAEF% in the LBBAP group was significantly improved compared with the RVOP group (60.02 ± 1.88 vs. 53.65 ± 2.45, p = .047) and baseline (60.02 ± 1.88 vs. 49.68 ± 2.75, p < .05) at 6 months after the surgery. (4) Left ventricular ejection index: The LVEF% in the LBBAP group was significantly increased than the RVOP group after 6 months (69.14 ± 4.99 vs. 64.60 ± 4.84, p = .01) and the BNP level was significantly lower in the LBBAP group compared with the RVOP group at 7 days, 1, 3, and 6 months after implantation (p < .05). (5) 6-min walking distance: the 6-min walking distance was significantly increased at 3 and 6 months after implantation compared with that before (p < .05) in both groups, but was more prominent in LBBAP groups ([483.03 ± 11.02] m vs. [431.09 ± 10.69] m,p < .05).
Compared with the traditional RVOP, the LBBAP procedure increased left atrial myocardial stress as well as left atrial ejection in pace-dependent patients at follow-up to 6 months.
最近的研究表明,与传统的右心室流出道间隔起搏(RVOP)相比,左束支区域起搏(LBBAP)在减少 QRS 时限和产生更低的起搏阈值方面具有更好的疗效,从而导致更好的心脏功能和心室同步性。然而,在依赖起搏器的患者中,LBBAP 是否在改善左心房结构和功能方面比 RVOP 更有效,尚未得到很好的研究。
本研究旨在比较依赖起搏器的患者接受 LBBAP 或 RVOP 治疗后的心房结局。
本研究共纳入 72 例(包括 II°AVB、高 AVB 和 III°AVB,不包括伴有房室阻滞的心房颤动患者)连续入组的单中心前瞻性临床研究患者,并随机分为 RVOP 组和 LBBP 组,每组 36 例。所有患者均为依赖起搏器的患者。记录并比较两组患者在植入前后的超声心动图、斑点追踪超声心动图、脑利钠肽(BNP)和 6 分钟步行距离的变化。两组患者的基线特征无显著差异。研究结果如下:(1)左心房结构指数:我们的研究表明,两组间左心房前后径(LAAPD)、左心房上下径和左心房内外径无显著差异。而 LBBAP 组在植入后 6 个月时 LAAPD 明显减小[38.22±2.17]mm 比[34.13±1.59]mm,p<0.05]。(2)左心房应变指数:我们观察到两组患者在植入后 3 个月和 6 个月时 S%均显著改善,但 LBBAP 组在 6 个月时更为明显[36.94±11.67 比 25.87±8.93,p=0.01]。SRs、SRe 在 RVOP 组植入后 6 个月时改善,但在 LBBAP 组进一步显著增加。同样,LBBAP 组的 SRa 在 6 个月时也明显优于 RVOP 组[-2.11±0.75 比-2.51±0.70,p=0.04]。(3)左心房射血指数:LBBAP 组的左心房射血分数(LAEF%)与 RVOP 组相比明显改善(60.02±1.88 比 53.65±2.45,p=0.047),与基线相比(60.02±1.88 比 49.68±2.75,p<0.05)在术后 6 个月时明显改善。(4)左心室射血指数:LBBAP 组的左心室射血分数(LVEF%)在植入后 6 个月时明显高于 RVOP 组(69.14±4.99 比 64.60±4.84,p=0.01),植入后 7 天、1 个月、3 个月和 6 个月时 LBBAP 组的 BNP 水平明显低于 RVOP 组(p<0.05)。(5)6 分钟步行距离:两组患者在植入后 3 个月和 6 个月时的 6 分钟步行距离均明显高于植入前(p<0.05),但 LBBAP 组更为显著[(483.03±11.02)m 比(431.09±10.69)m,p<0.05]。
与传统的 RVOP 相比,LBBAP 术式在随访 6 个月时增加了依赖起搏器患者的左心房心肌张力和左心房射血。